CP6679, a new injectable cephalosporin. Part 1: Synthesis and structure-activity relationships

A series of cephalosporins bearing a 5,5-fused ring system, an (imidazo[5,1-b]thiazolium-6-yl)methyl group, at the C-3 position were synthesized and evaluated for in vitro antibacterial activities. CP6679 (1s) and its analogues showed potent antibacterial activities against gram-positive and gram-ne...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry Vol. 8; no. 12; pp. 2781 - 2789
Main Authors: TSUSHIMA, Masaki, IWAMATSU, Katsuyoshi, TAMURA, Atsushi, ATSUMI, Kunio, UMEMURA, Eijiro, KUDO, Toshiaki, SATO, Yasuo, SHIOKAWA, Sojiro, TAKIZAWA, Hiromasa, KANO, Yuko, KOBAYASHI, Kazuko, IDA, Takashi
Format: Journal Article
Language:English
Published: Oxford Elsevier Science 01-12-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of cephalosporins bearing a 5,5-fused ring system, an (imidazo[5,1-b]thiazolium-6-yl)methyl group, at the C-3 position were synthesized and evaluated for in vitro antibacterial activities. CP6679 (1s) and its analogues showed potent antibacterial activities against gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa. They were also highly active against methicillin-resistant Staphylococcus aureus (MRSA). CP6679 (1s) showed more potent antibacterial activity than ceftazidime (CAZ) or cefpirome (CPR) against Pseudomonas aeruginosa and MRSA.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/s0968-0896(00)00214-5